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Aging is both a natural and inevitable biological process.
With advancing age, the kidneys undergo anatomical and
physiological changes that are not only the consequences of
normal organ senescence but also of specific diseases (such
as atherosclerosis or diabetes) that occur with greater
frequency in older individuals. Disentangling these two
processes, one pathologic and the other physiologic, is
difficult. In this review we concentrate on the glomerular
structural and functional alterations that accompany natural
aging. We also analyze how these changes affect the
identification of individuals of advancing age as having
chronic kidney disease (CKD) and how these changes can
influence prognosis for adverse outcomes, including all-cause
mortality, end-stage renal disease, cardiovascular events and
mortality, and acute kidney injury. This review describes
important shortcomings and deficiencies with our current
approach and understanding of CKD in the older and
elderly adult.
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Normal aging of the kidneys must be discussed in the context
of the various meanings of the term normal.1 Epidemiologists
often use the term in a statistical sense to describe the usual
range of variation, both in health and disease, as it appears in
the unselected general population. The use of this definition
and the currently used classification systems for chronic
kidney disease (CKD) explains the very high reported
prevalence of CKD in the elderly. CKD is diagnosed in
healthy elderly subjects whose renal function is below a
notional normal range. The more colloquial definition of
normal implies good health for age. How does the anatomy
of the kidney change with ‘natural and healthy’ aging in the
absence of either a specific kidney disease or CKD risk
factors? The term ‘senescence’ as opposed to ‘disease’ may
also be used to describe these more predictable and
physiological changes with aging. This latter approach to
defining normal is commonly used for laboratory reference
ranges.2 Further, with living kidney donation there is a need
to clarify what is normal for the age of the kidneys, lest only
young adults be permitted to be kidney donors. These living
kidney donors also provide a unique opportunity to study
normal aging by this latter definition, as kidney donors are
systematically evaluated for CKD, and kidney tissue is often
available for microscopic examination. Although not every
marker of CKD has been discovered, and occult disease may
remain undetected, existing evidence finds that even 70-year-
olds with optimal health for their age have features of
senescence in their kidneys not seen in healthy 20-year-olds.
This controversy has been reviewed on many occasions,3–9
but this review will focus on a contemporary analysis of the
changes of glomerular structure and function with aging and
their clinical consequences.
BIOPSY STUDIES OF MICROANATOMY
Glomerular, arterial, and tubulo-interstitial alterations
in the aging kidney
The age-related findings on light microscopic evaluation of
kidney biopsies can be divided into two groups: (1) nephro-
sclerosis and its features (glomerulosclerosis, tubular atrophy,
interstitial fibrosis, and arteriosclerosis) and (2) morphometric
analysis of microanatomy (particularly glomerular size).
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Numerous studies have shown an increased proportion of
globally sclerotic glomeruli with aging.10–16 Even in living
kidney donors there is an increased prevalence of glomerulo-
sclerosis on the renal biopsy throughout the age spectrum:
19%, 38%, 47%, 65%, 76%, and 82% in the 18- to 29-, 30- to
39-, 40- to 49-, 50- to 59-, 60- to 69-, and 70- to 77-year-old
age groups, respectively.16 The glomerulosclerosis that occurs
with aging has an ischemic appearance with tuft collapse and
intracapsular fibrosis, suggesting a primary vascular origin for
the lesions. Some functional glomeruli also show ischemic
capillary wrinkling of tufts, thickening of basement mem-
branes, and mild intra-capsular fibrosis, all of which are
precursors for glomerulosclerosis. Over time, shrinkage of the
glomerular tufts toward the vascular pole with eventual
sclerosis and collagen deposition filling Bowman’s space
develops.17,18 Besides glomerulosclerosis, increased arterio-
sclerosis (fibrointimal hyperplasia), medial hypertrophy, and
arteriolar hyalinosis occur with aging.12,16 With the sclerosis of
juxtamedullary glomeruli, there is formation of a direct
connection between afferent and efferent arterioles that
bypasses the tuft.19 Tubular atrophy with surrounding areas
of interstitial fibrosis also increases with aging.15,16,20
The concept of nephrosclerosis in the aging kidney
Glomerulosclerosis, arteriosclerosis, tubular atrophy, and
interstitial fibrosis occur commonly together, and this
constellation of findings constitutes nephrosclerosis. Indeed,
it is hypothesized that fibro-intimal hyperplasia in small
arteries with aging leads to glomerulosclerosis, followed by
local tubular atrophy and interstitial fibrosis.21 A sclerosis
score can be defined by the number of these different
histological abnormalities present on an implantation biopsy
of living kidney donors (Figure 1). Nephrosclerosis, defined
by two or more of these abnormalities, increases progressively
with age: 2.7% for 18- to 29-, 16% for 30- to 39-, 28% for
40- to 49-, 44% for 50- to 59-, 58% for 60- to 69-, and 73%
for 70- to 77-year-olds. Nephrosclerosis may be universal in
centenarians. An age-related decline in glomerular filtration
rate (GFR) was not explained by these histological changes
occurring with normal aging.16
Other histomorphometric changes in the aging kidney
Discrepant findings exist among studies of changes in the
average glomerular size with aging. Some have reported the
glomerular surface area or volume to decline with age,14,22
whereas others have found no change11 or an increase with
age.23–25 It is not clear from these studies whether sclerotic
glomeruli were excluded or included in the measurement of
average glomerular size. The sclerotic glomeruli seen with aging
are smaller than functional glomeruli and would contribute to
any decline in average glomerular size with aging. However,
compensatory hypertrophy of the remaining functional glome-
ruli also develops in response to sclerotic (presumed nonfunc-
tional) glomeruli.24,26 Thus, both an increase in the proportion
of small sclerosed glomeruli and an increase in the size of
functional glomeruli may occur with age.
Besides glomerular size, glomerular density (number of
glomeruli per area of cortex) is an inversely proportional
surrogate for the average nephron size.27 Glomerular density
inversely correlates with glomerular size and is a potent
predictor of GFR decline in early IgA and membranous
nephropathy.28,29 A decrease in glomerular density with aging is
noted in biopsy samples where sclerotic glomeruli areo10% of
the total glomerular population, consistent with an increased
size of glomeruli and tubules with aging. Conversely, glome-
rular density increases with aging in biopsy samples where
sclerotic glomeruli are 410% of the total glomerular popula-
tion (Figure 2). This latter process becomes more dominant
with age, as the proportion of small sclerotic glomeruli increases
and there is more tubular atrophy.27 Autopsy microdissection
studies have shown that tubular diverticula are also observed
with increased frequency with aging.14
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Figure 1 |Mosaic plot of sclerosis scores by age group among
1203 living kidney donors. Sclerosis score defined as the total
number of chronic histological abnormalities between (1) any
global glomerulosclerosis, (2) any tubular atrophy, (3) interstitial
fibrosis45%, and (4) any arteriosclerosis. In the figure, a score of
0 is white, a score of 4 is orange, and intermediate scores are on a
color intensity scale. The figure is used with permission.97
Lo
g 
(gl
om
eru
la
r d
en
sit
y)
0.6
0.7
0.9
0.8
1.0
<10% Glomerulosclerosis
>10% Glomerulosclerosis
20 30 40 50 60 70
Age in years
Figure 2 | Logarithmic glomerular density by age for persons
with p10% (solid smoothing spline) or with 410% (dashed
smoothing spline) glomerulosclerosis among 1046 living
kidney donors. The figure is used with permission.27
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AUTOPSY AND IMAGING STUDIES OF MACROANATOMY
Kidney weight with aging in autopsy studies
Autopsy studies allow thorough assessment of the macro-
anatomy of the kidney, as well as concurrent sectioning and
staining for the microanatomy of the cortical parenchyma.
The main disadvantage of autopsy studies for studying
normal aging is that the underlying renal pathology may
have contributed to the cause of death. Substantially less renal
pathology is observed among deceased kidney donors
compared with autopsied patients at the same age, even after
excluding known CKD and CKD risk factors.15 In autopsy
series, a decrease in the kidney weight with age appears to
begin in the fourth to fifth decade and results in a 10–30%
decrease in kidney weight by the seventh to eighth decade.30,31
In a study limited to normal individuals with sudden death,
there was no association between kidney weight and age after
adjusting for body surface area.32
Kidney volume does not change with normal aging
Assessment of the kidney size and other anatomical changes
with age can be performed readily with ultrasound and
computed tomography, in healthy individuals. As with
autopsy studies, imaging studies in populations that exclude
persons with comorbidity show less decline in the kidney
volume with age than the studies that do not have this
exclusion. In particular, studies in potential kidney donors
have not found any evidence of a decline in kidney volume by
computed tomography scan with age, although few persons
over the age of 60 years were included.33–35 Factors other than
age that seem to be more strongly correlated with kidney
parenchymal volume include gender, body surface area
(height and weight), and GFR. Imaging studies in populations
with less exclusion of comorbidity, with larger sample sizes,
and with older adults do find a decline in kidney parenchymal
volume with age.36–38 The loss of kidney mass with age is
accelerated with severity of atherosclerosis (as estimated from
carotid intima-media thickness).39 An increase in renal sinus
fat with age may compensate for the decrease in the kidney
parenchymal volume with age.36,37
Compensation of functional nephrons preserves kidney
volume
Given the marked increase in glomerulosclerosis and tubular
atrophy with age in kidney donors,16 why does kidney volume
not decline in this population? The answer appears to be a
compensatory increase of the volume of unaffected nephrons
in response to loss of nephrons affected by glomerulosclerosis
and tubular atrophy.11 There is both increased volume of
functional glomeruli and decreased glomerular density with
aging.23,24,26,27 There may be a threshold to this compensa-
tion around the age of 60 years, when the glomerular density
no longer decreases because of enhancement of lesions of
glomerulosclerosis and tubular atrophy (Figure 2).27 This
hypothesis is consistent with autopsy and imaging studies
that show an accelerated loss of parenchymal volume after
middle age.30,31,40
Other imaging pathology of the aging kidney
In a series of 1957 potential kidney donors undergoing
computed tomography angiograms and urograms, the
prevalence of renal artery fibromuscular dysplasia and
narrowing from atherosclerosis, focal scarring (focal cortical
thinning), parenchymal calcification, and suspicious or
indeterminate masses all increased with age.41 Simple renal
cysts also become increasingly prevalent with age.42,43 Renal
tubular diverticula that occur with aging are hypothesized to
be the source of these simple cysts.14,44
The number of functional glomeruli declines with normal
aging
Using stereological techniques, autopsied kidneys can be
carefully sectioned to estimate the total number of glomeruli
present. Given the increased proportion of sclerosed glomer-
uli, it is not surprising that the total number of functional
glomeruli decreases with age.11 A less precise technique to
determine the number of glomeruli in living kidneys is to
multiply the cortical volume (imaging study) with the
glomerular density in the cortex (renal biopsy). By this
technique, the number of functional glomeruli also appears to
decrease with the kidney donor’s age.25 There is an alternative
approach for estimating the total number of functional
glomeruli. The ultrafiltration coefficient (Kf) of the whole
kidney is estimated from direct GFR and renal plasma flow
(RPF) measurements. The average estimated Kf of individual
glomeruli is calculated from light and electron microscopic
measurements from the renal biopsy. The total number of
functioning glomeruli is then estimated from the whole
kidney Kf divided by the single nephron Kf.
45–47 Using this
technique, the numbers of functional glomeruli appear to be
substantially decreased in older compared with younger
kidney donors.46,47 What remains unclear is whether the total
number of glomeruli (sclerosed and functioning) changes
with age because of a process of glomerular resorption.
Nephron endowment (the number of glomeruli a person is
born with) is largely impacted by birth weight,48 and whether
nephron endowment affects age-related changes in the kidney
is unclear.
RENAL FUNCTIONAL CHANGES WITH AGING
Changes in GFR with aging
The alterations in renal function that accompany aging have
been the focus of attention for over a half century. In the
classic work of Homer Smith,49 a decline in standard urea
clearance from 100% at the age of 30 years to 55% at the age
of 89 years was described. The seminal contribution of Davies
and Shock in 1950 (ref. 50) cemented the notion of an
inexorable decline of GFR with aging. They studied 70 men
(aged 25–89 years) free of clinical signs or a history of kidney
or heart disease—some were normal volunteers, whereas others
were hospitalized or were residents of a nursing facility with a
variety of ‘chronic diseases’ including tuberculosis, syphilis,
or generalized arteriosclerosis. Isolated systolic or systolic/
diastolic hypertension was present in 11 of 70 subjects, 9 of
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whom were over 60 years of age. GFR measured by renal
inulin clearance declined linearly beginning at the age of 30
years from an average of 123ml/min per 1.73m2 to 65ml/
min per 1.73m2 at the age of 90 years (a 46% decline). The
decline in RPF roughly paralleled the decline in GFR, although
there was a slight increase in RPF at the age of 70 years and
beyond. These early studies were all cross-sectional in nature.
This deficit was corrected in 1985 by the report of
Lindeman, Tobin, and Shock51 on longitudinal studies of the
rate of decline in renal function with age in the Baltimore
Longitudinal Study of Aging. A total of 254 presumably
‘normal’ subjects (all men without renal disease or hyperten-
sion but some with non-proteinuric diabetes) were studied
with serial urinary true endogenous creatinine clearance (Ccr)
over a 5- to 14-year period. The average decline of Ccr was
0.75ml/min/year. The calculated slopes of Ccr vs. time
followed a normal Gaussian distribution. As many as 1/3 of
the subjects showed a stable Ccr over time. A small number
showed an actual increase in Ccr with aging. It was never
reported whether the presence of diabetes and hyperglycemia
(and concomitant ‘hyperfiltration’) influenced these increasing
Ccr results. The statistical analysis did not adequately account
for imprecision of Ccr measures, the limited number of
observations, and multiple hypothesis testing; relatively few of
the increasing slopes were likely a true increase in function.
Nevertheless, this study has been widely cited to challenge the
concept that the decline in renal function with age is
inexorable. Rowe et al.52 had earlier studied many of the same
subjects for changes in renal function also by means of Ccr. In
548 ‘normal’ subjects, the average Ccr was 140ml/min per
1.73m2 at the age of 30 years and declined to 97ml/min per
1.73m2 at the age of 80 years (a 31% difference). Longitudinal
data on 293 ‘normal’ subjects suggested an acceleration of the
decline with advancing age. They concluded that the decline in
Ccr with aging is true ‘physiological’ renal aging (senescence),
and not secondary to diseases that become more prevalent
with advancing age.
Many years later, the controversy regarding the inevitability
of the decline in renal function with aging was reawakened by
Fliser et al.53,54 These authors suggested that the elderly
population was heterogeneous—some have a decline in GFR
explained by diseases that complicate aging (such as severe
hypertension or congestive heart failure), whereas in the most
healthy the decline in GFR is much more modest and not
inevitable. Fliser et al. also proposed that the renal functional
changes accompanying aging might be the consequence of an
altered responsiveness to vasodilators (such as L-arginine,
nitric oxide, acetylcholine and dopamine) and vasoconstric-
tors (angiotensin, nor epinephrine, endothelin).55 This thesis
is based largely on observations that the filtration fraction
increases with aging, due to a disproportionate fall in RPF
relative to GFR.55–57 As noted above, the filtration fraction
does not apparently begin to increase until after the age of 60
or 70 years, yet the decline in GFR begins at age 30–40 years, at
least in cross-sectional studies. Nevertheless, it is clear that
the aging kidney shows impaired endothelium-dependent
vasodilatation (an nitric oxide–dependent response), particu-
larly in the presence of hypertension (and albuminuria).58–60
Accumulation of asymmetric dimethyl arginine, an endogen-
ous inhibitor of nitric oxide synthetase, may be partly
responsible for the imbalance of vasodilatation and vasocon-
striction in the aging kidney.61 In a classic study of renal
vascular responses in normal aging men, Hollenberg et al.59
found that the vasodilatory response to acetylcholine or to an
acute sodium load was impaired with aging, whereas the vaso-
constrictive response to angiotensin was not altered with
aging, consistent with a fixed (anatomic) lesion of blood
vessels.59 Collectively, these studies strongly indicate that
senescent changes in renal function are driven primarily by a
vascular process. Lindeman et al.62 had previously shown that
aging subjects without hypertension (mean arterial pressure
o107mmHg) demonstrate much less decline of Ccr with aging,
but a cause and effect relationship cannot be proven by such data.
Two additional observations are worth considering. One is
the elegant studies of Hollenberg et al.63–65 in the Kuna
Indians of Panama. This island-dwelling indigenous popula-
tion (culturally adapted to consumption of large amounts of
flavone throughout life) is remarkably free of the cardiovas-
cular (CV) diseases commonly affecting the elderly in non-
island Panamanians, and they do not show any progressive
increase in blood pressure with age. Both GFR and RPF
decline with age in the Kuna Indians—indeed, the slope of
RPF and GFR relative to age was greater in the Kuna Indians
compared with age-matched residents of Boston. This is one
of the few studies that potentially disassociate the diseases of
aging that are often attributed to a modern lifestyle from the
renal function changes accompanying normal senescence. The
second observation concerns changes in renal function in
living donors of kidney allografts.66–68 Kidney donors are
rigorously evaluated to ensure ‘health’ before donation, yet
these cross-sectional studies consistently show a progressive
decline in GFR with age even after excluding donors with
CKD or CKD risk factors.
Estimation of GFR with serum creatinine in aging
Because of the complexity of direct measurement of GFR
(mGFR) by infusion of exogenous substances (e.g., iothala-
mate), formulas have been devised to estimate GFR (eGFR)
from the serum concentration of endogenous markers that are
filtered at the glomerulus.69–71 Creatinine is the endogenous
marker that has been most widely used. The Cockcroft–Gault
(C–G) formula,69 which estimates endogenous Ccr in ml/min
not adjusted for body surface area, and the modification of
diet in renal disease formula (eGFR-MDRD), which estimates
GFR in ml/min adjusted to standard body surface area of
1.73m2,70 are among the best studied serum creatinine
(Scr)–based equations. A newer modification of the eGFR
known as the CKD-EPI equation71 uses the same variables as
the MDRD equation but was developed using a more diverse
sample of patients. All creatinine-based equations contain age
and gender as variables (only the C–G formula contains a
weight variable). The inclusion of age (and gender) in the Scr-
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based equations is to provide ‘surrogacy’ for anticipated
endogenous creatinine production rate, which inevitably
declines with age most likely due to loss of lean body mass.5
Numerous cross-sectional studies have shown that eGFR
(MDRD) and eCcr (C–G) decline with age in a manner very
similar to that described by studies of mGFR, cited above,
although the absolute values vary.66–68,72,73 Figure 3 shows a
representative study of eGFR (MDRD) in normal ‘healthy’
kidney transplant donors.66 Note that the mean value for
eGFR (MDRD) is about 105ml/min per 1.73m2 for 18- to 24-
year-old male subjects (about 11% lower than average mGFR)
and is about 102ml/min per 1.73m2 for 18- to 24-year-old
female subjects (about 7% lower than average mGFR). The
mean eGFR (MDRD) declines to about 80ml/min per 1.73m2
and 78ml/min per 1.73m2 in 65-year-old men and women,
respectively. This equates to a 25ml/min per 1.73m2 or 24%
decline in eGFR over 45 years of age for men and women,
respectively.
These values for ‘normal’ eGFR (MDRD) in aging
populations have important implications for the diagnosis
of CKD in the elderly.74,75 Since 2002, with the publication of
the NKF-KDOQI classification and staging schema for
CKD,76 it has been possible to diagnose CKD solely on the
basis of an isolated eGFR (MDRD) value of o60ml/min per
1.73m2. Inspection of Figure 3 demonstrates that a significant
fraction of apparently normal aged individuals over the age of
60 years (more women than men) have eGFR values that are
below 60ml/min per 1.73m2 but nearly always above 45ml/
min per 1.73m2. In the eGFR 45–59ml/min per 1.73m2 range
for healthy adults (kidney donors), the MDRD equation
underestimates mGFR by 25% and the CKD-EPI equation
underestimates mGFR by 16%.77 This likely occurs because
these equations were developed using CKD patients with
decreased muscle mass compared with healthy adults. This
bias, combined with the relatively poor precision of the eGFR
formulas in the range of 460ml/min per 1.73m2,70,78 can
lead to misclassifying (overdiagnosing) ‘healthy’ older persons
as having a ‘disease.’ This is the inevitable consequence of
adopting a fixed threshold of eGFR for identifying CKD,
without making some adjustment for the variation of eGFR
seen with age and gender.9,74,75 With current criteria, the great
majority of subjects diagnosed as having CKD Stage 3 are over
65 years of age.79
Outcomes with modestly reduced eGFR in aging subjects
On the other hand, there would be justification for such
identification of CKD if a modestly reduced creatinine-based
eGFR (45–59ml/min per 1.73m2) was predictive of adverse
outcomes among older adults. Such an adverse prognostic
effect of a lower eGFR in older subjects has been the
subject of intense investigation and some general principles
have now been clarified, as a result of large observa-
tional studies and meta-analyses.80–91 These are summarized
below:
(i) Older patients with an eGFR of 45–59ml/min per
1.73m2 are less likely than younger patients to progress
to treated end-stage renal disease, and when progression
does occur it is slower than that in younger patients.87,88
(ii) Younger patients with an eGFR of 45–59ml/min per
1.73m2 are at increased risk of dying (usually of CV
disease). This effect is attenuated with advancing age,
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Figure 3 |A comparison of estimated glomerular filtration rate
(GFR) in two ‘normal’ cohorts according to age. (a) Men;
(b) Women. Blue lines indicate mean, 90% UPL and LPL estimated
glomerular filtration rate (eGFR; modification of diet in renal
disease formula (MDRD), re-expressed equation) in healthy living
donors. Orange lines indicate median, 5th, and 95th percentiles
for ‘normal’ Caucasian community living adults from the
Nijmegen Biomedical Study. UPL, upper probability limit;
LPL, lower probability limit. The figure is used with
permission.66
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and some data even suggest that older patients with an
eGFR of 45–59ml/min per 1.73m2 are not at any increased
risk of dying, after correction for effect of age.88,89
(iii) Concomitant proteinuria (albuminuria) is an impor-
tant magnifier of risk for all-cause mortality, end-stage
renal disease, and CVevents. Elderly subjects (above the
age of 70 years) without abnormal albuminuria and
with only an eGFR of 45–59ml/min per 1.73m2 are not
at greatly increased risk for overall mortality compared
with those with an eGFR460ml/min per 1.73m2 and
no albuminuria.81 The threshold for increased CV
mortality in the older adult (465 years) appears to be
at about 45ml/min per 1.73m2 and lower, and an
albumin excretion rate of over 9mg/day.91
(iv) The actual relative risk of mortality depends on the
reference group, as mortality is elevated in both higher
and lower strata of eGFR (‘U-shaped’ effect). Several
studies have used a value for eGFR of 95ml/min per
1.73m2 as the reference group. This likely inflates risk
estimates because persons with low Scr levels from
muscle wasting conditions are excluded from the
reference group.80,85,86
(v) Clinical renal outcomes (kidney failure and acute renal
failure) are increased in the elderly at a modestly
reduced eGFR of 45–59ml/min per 1.73m2 compared
with an eGFR 460ml/min per 1.73m2 even after
excluding persons with albuminuria.80,90
Whether a creatinine-based eGFR at levels of 45–59ml/
min per 1.73m2 at ages over 65 years can be considered an
important independent risk factor for CV disease is doubt-
ful.92 Adding eGFR (MDRD equation) to risk estimation
among 27,620 subjects over the age of 55 years with
documented CV disease contributed nothing of value to
reassignment of risk compared with traditional risk scoring.92
It seems clear that the use of risk stratification to define a
disease has its inherent limitations.
The problematic age variable in eGFR
It should be remembered that all creatinine-based equations
for estimation of eGFR contain an age variable. This can
confound the observed relationship of eGFR with both all-
cause mortality and CV morbidity and mortality, as age is
itself a strong factor predisposing to both. Further, the use of
age instead of actual muscle mass with creatinine-based
equations for eGFR inflates both prevalence estimates of CKD
and risk estimates of adverse outcomes in the elderly.93
Scr-based eGFR determinations also assume that sarco-
penia is inevitable with aging, as age is used as a surrogate for
muscle mass in these equations. To put this in perspective,
consider a 20-year-old woman with an Scr level of 1.0mg/dl.
If there is no change in her Scr level with aging, she will
still have developed CKD (Stage 3) by the time she is 50 years
old (eGFR-MDRD¼ 59ml/min per 1.73m2). It will be
argued that she developed CKD that was not detected by a
change in Scr level, because as she aged she lost muscle mass
at the same rate as she lost GFR. But why is the age-related
decline in GFR considered less inevitable and more of a
disease than the age-related sarcopenia? If both age-related
decline in GFR and sarcopenia were preventable, then
this hypothetical patient could continue to have an Scr
level of 1.0mg/dl well into old age, but would still be labeled
with CKD.
Estimation of GFR with cystatin C in aging
Cystatin C–based eGFR measurements appear to be superior
for predicting morbidity and mortality risk,94,95 but this may
be the result of Cystatin C levels covarying with underlying
inflammation, which can itself be a factor in CV disease.96
Nevertheless, there are likely two different populations within
a cohort of elderly persons with eGFR (MDRD or CKD-EPI)
values of 45–59ml/min per 1.73m2—fit persons with well-
preserved muscle mass and a senescence-related (benign)
decline in GFR and those with actual CKD. In this setting, a
confirmatory test such as an elevated cystatin C level might
be helpful before the diagnosis of bona fide CKD can made.
Indeed, the risk of adverse outcomes is only increased among
those with a creatinine-based eGFRo60ml/min per 1.73m2
who also have a Cystatin C–based eGFR o60ml/min per
1.73m2.95
CONCLUSIONS
Normal aging is accompanied by progressive nephrosclerosis
(glomerulosclerosis, tubular atrophy, arteriosclerosis, and
interstitial fibrosis). Despite volume-losing lesions of glo-
merulosclerosis and tubular atrophy, overall kidney volume
appears to be stable with aging, except in the very elderly.
Compensatory hypertrophy of unaffected nephrons seems to
preserve kidney volume. Indeed, glomerular size increases
and glomerular density decreases with aging. GFR also declines
with normal aging, but this is not clearly explained by changes
in glomerular size, density, or glomerulosclerosis. Creatinine-
based eGFR is imprecise and substantially underestimates
mGFR. This contributes to the overdiagnosis of CKD in the
elderly. Confirmatory testing with cystatin C and urine albumin
excretion might help clarify which elderly truly have CKD and
are at increased risk for disease-related adverse events. To the
extent that a GFR decline is inevitable with aging, the use of a
single GFR threshold for diagnosing CKD is not clearly justified.
DISCLOSURE
All the authors declared no competing interests.
ACKNOWLEDGMENTS
This work was supported by the National Institutes of Health,
National Institute of Diabetes and Digestive and Kidney Diseases (R01
DK 090358 and K23DK078229). We also thank Dr Christopher
Winearls for his review of an earlier version of this manuscript.
REFERENCES
1. Last JM, Spasoff RA, Harris SS (eds). A Dictionary of Epidemiology, 4th edn.
University Press: Oxford, 2001.
2. Suggestions for Laboratories. In http://www.nkdep.nih.gov, National
Kidney Disease Education Program, 2003.
Kidney International (2012) 82, 270–277 275
RJ Glassock and AD Rule: The aging kidney rev iew
3. Lindeman RD, Goldman R. Anatomic and physiologic age changes in the
kidney. Exp Gerontol 1986; 21: 379–405.
4. Lindeman RD. Overview: renal physiology and pathophysiology of aging.
Am J Kidney Dis 1990; 16: 275–282.
5. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7: 1106–1122.
6. Zhou XJ, Rakheja D, Yu X et al. The aging kidney. Kidney Int 2008; 74:
710–720.
7. Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys
including changes in GFR. Nephron Clin Pract 2011; 119(Suppl 1): 1–5.
8. Abdelhafiz AH, Brown SH, Bello A et al. Chronic kidney disease in older
people: physiology, pathology or both. Nephron Clin Pract 2010; 116:
c19–c248.
9. Glassock RJ, Winearls CG. Ageing and the glomerular filtration rate: truths
and consequences. Trans Am Clin Climatol Assoc 2008; 120: 419–428.
10. Vazquez Martul E, Veiga Barreiro A. Importance of kidney biopsy in graft
selection. Transplant Proc 2003; 35: 1658–1660.
11. Hoy WE, Douglas-Denton RN, Hughson MD et al. A stereological study of
glomerular number and volume: preliminary findings in a multiracial
study of kidneys at autopsy. Kidney Int Suppl 2003; 63: S31–S37.
12. Kubo M, Kiyohara Y, Kato I et al. Risk factors for renal glomerular and
vascular changes in an autopsy-based population survey: the Hisayama
study. Kidney Intl 2003; 63: 1508–1515.
13. Kaplan C, Pasternack B, Shah H et al. Age-related incidence of sclerotic
glomeruli in human kidneys. Am J Pathol 1975; 80: 227–234.
14. Darmady EM, Offer J, Woodhouse MA. The parameters of the ageing
kidney. J Pathol 1973; 109: 195–207.
15. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the
normal human kidney, related to age and sex. A quantitative study.
Virchows Archiv 1980; 387: 271–277.
16. Rule AD, Amer H, Cornell LD et al. The association between age and
nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med
2010; 152: 561–567.
17. Zhou X, Zoltona G, Silva F. Anatomical changes in the aging kidney. In:
Macias Nunez J, Cameron JS, Oreopoulos D (eds). The Aging Kidney in
Health and Disease. Springer Science+Business Media, LLC: New York,
2008, pp 39–54.
18. Wiggins JE, Goyal M, Sanden SK et al. Podocyte hypertrophy, ‘adaptation,’
and ‘decompensation’ associated with glomerular enlargement and
glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am
Soc Nephrol 2005; 16: 2953–2966.
19. Takazakura E, Sawabu N, Handa A et al. Intrarenal vascular changes with
age and disease. Kidney Intl 1972; 2: 224–230.
20. Mancilla E, Avila-Casado C, Uribe-Uribe N et al. Time-zero renal biopsy in
living kidney transplantation: a valuable opportunity to correlate
predonation clinical data with histological abnormalities. Transplantation
2008; 86: 1684–1688.
21. Martin JE, Sheaff MT. Renal ageing. J Pathol 2007; 211: 198–205.
22. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to
age, kidney weight, and body surface in normal man. Anat Rec 1992;
232: 194–201.
23. Goyal VK. Changes with age in the human kidney. Exp Gerontol 1982;
17: 321–331.
24. Abdi R, Slakey D, Kittur D. Heterogeneity of glomerular size in normal
donor kidneys: impact of race. Am J Kidney Dis 1998; 32: 43–46.
25. Fulladosa X, Moreso F, Narvaez JA et al. Estimation of total glomerular
number in stable renal transplants. J Am Soc Nephrol 2003; 14:
2662–2668.
26. McLachlan MS. The ageing kidney. Lancet 1978; 312: 143–145.
27. Rule AD, Semret MH, Amer H et al. Association of kidney function and
metabolic risk factors with density of glomeruli on renal biopsy samples
from living donors. Mayo Clinic Proc 2011; 86: 282–290.
28. Tsuboi N, Kawamura T, Koike K et al. Glomerular density in renal biopsy
specimens predicts the long-term prognosis of IgA nephropathy. Clin J
Am Soc Nephrol 2010; 5: 39–44.
29. Tsuboi N, Kawamura T, Yoichi M et al. Low glomerular density is a risk
factor for progression in idiopathic membranous nephropathy. Nephrol
Dial Transplant 2011; 26: 3425–3426.
30. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the
different races. Gerontologia 1971; 17: 87–97.
31. Rao UV, Wagner Jr HN. Normal weights of human organs. Radiology 1972;
102: 337–339.
32. Kasiske BL, Umen AJ. The influence of age, sex, race, and body habitus on
kidney weight in humans. Arch Pathol Lab Med 1986; 110: 55–60.
33. Johnson S, Rishi R, Andone A et al. Determinants and functional
significance of renal parenchymal volume in adults. Clin J Am Soc Nephrol
2011; 6: 70–76.
34. Herts BR, Sharma N, Lieber M et al. Estimating glomerular filtration rate in
kidney donors: a model constructed with renal volume measurements
from donor CT scans. Radiology 2009; 252: 109–116.
35. Jeon HG, Lee SR, Joo DJ et al. Predictors of kidney volume change and
delayed kidney function recovery after donor nephrectomy. J Urol 2010;
184: 1057–1063.
36. Gourtsoyiannis N, Prassopoulos P, Cavouras D et al. The thickness of
the renal parenchyma decreases with age: a CT study of 360 patients.
Am J Radiol 1990; 155: 541–544.
37. Emamian SA, Nielsen MB, Pedersen JF et al. Kidney dimensions at
sonography: correlation with age, sex, and habitus in 665 adult
volunteers. Am J Radiol 1993; 160: 83–86.
38. Glodny B, Unterholzner V, Taferner B et al. Normal kidney size and its
influencing factors—a 64-slice MDCT study of 1.040 asymptomatic
patients. BMC Urology 2009; 9: 19.
39. Bax L, van der Graaf Y, Rabelink AJ et al. Influence of atherosclerosis
on age-related changes in renal size and function. Eur J Clin Invest
2003; 33: 34–40.
40. McLachlan M, Wasserman P. Changes in sizes and distensibility of the
aging kidney. Brit J Radiol 1981; 54: 488–491.
41. Lorenz EC, Lieske JC, Vrtiska TJ et al. Clinical characteristics of potential
kidney donors with asymptomatic kidney stones. Nephrol Dial
Transplant 2011; 26: 2695–2700.
42. Tada S, Yamagishi J, Kobayashi H et al. The incidence of simple renal cyst
by computed tomography. Clin Radiol 1983; 34: 437–439.
43. Eknoyan G. A clinical view of simple and complex renal cysts. J Am Soc
Nephrol 2009; 20: 1874–1876.
44. Baert L, Steg A. Is the diverticulum of the distal and collecting tubules a
preliminary stage of the simple cyst in the adult? J Urol 1977; 118:
707–710.
45. Hoang K, Tan JC, Derby G et al. Determinants of glomerular hypofiltration
in aging humans. Kidney Int 2003; 64: 1417–1424.
46. Tan JC, Busque S, Workeneh B et al. Effects of aging on glomerular
function and number in living kidney donors. Kidney Int 2010; 78:
686–692.
47. Tan JC, Workeneh B, Busque S et al. Glomerular function, structure, and
number in renal allografts from older deceased donors. J Am Soc Nephrol
2009; 20: 181–188.
48. Manalich R, Reyes L, Herrera M et al. Relationship between weight at birth
and the number and size of renal glomeruli in humans: a histomorphometric
study. Kidney Int 2000; 58: 770–773.
49. Smith H. The Kidney: Structure and Function in Health and Disease. Oxford
Medical Publications: New York, 1951, pp 552–562.
50. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective
renal plasma flow and tubular excretory capacity in adult males. J Clin
Invest 1950; 29: 496–507.
51. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the
rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:
278–285.
52. Rowe JW, Andres R, Tobin JD et al. The effect of age on creatinine
clearance in men: a cross-sectional and longitudinal study. J Gerontol
1976; 31: 155–163.
53. Fliser D, Franek E, Ritz E. Renal function in the elderly- is the dogma of an
inexorable decline of renal function correct? Nephrol Dial Transplant
1997; 12: 1553–1555.
54. Fliser D. Ren sanus in corpore sano: the myth of the inevitable decline of
renal function with senescence. Nephrol Dial Transplant 2005; 20:
482–485.
55. Fliser D, Ritz E. Renal hemodynamics in the elderly. Nephrol Dial
Transplant 1996; 11(Supplement 9): 2–8.
56. Fliser D, Ritz E. Relationship between hypertension and renal function
and its therapeutic implications in the elderly. Gerontol 1998; 44:
123–131.
57. Fliser D, Franek E Joest M, Block S et al. Renal function in the elderly:
impact of hypertension and cardiac function. Kidney Int 1997; 51:
1196–1204.
58. Barton M. Ageing as a determinant of renal and vascular disease: role of
endothelial factors. Nephrol Dial Transplant 2005; 20: 485–490.
59. Hollenberg NK, Adams DF, Solomon HS et al. Senescence and the renal
vasculature in normal man. Circ Res 1974; 34: 309–316.
60. Hollenberg NK, Moore TJ. Age and the renal blood supply: renal vascular
responses to angiotensin converting enzyme inhibition in healthy
humans. J Am Geriatric Soc 1994; 42: 805–808.
61. Kielstein JT, Bode-Boger SM, Haller H et al. Functional changes in the
ageing kidney: is there a role for asymmetric dimethylarginine? Nephrol
Dial Transplant 2003; 18: 1245–1248.
276 Kidney International (2012) 82, 270–277
rev iew RJ Glassock and AD Rule: The aging kidney
62. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure
and the rate of decline in renal function with age. Kidney Int 1984; 26:
861–868.
63. Hollenberg NK, Martinez G, McCullough M et al. Aging, acculturation, salt
intake and hypertension in the Kuna of Panama. Hypertension 1997; 29:
171–176.
64. Hollenberg NK, Rivera A, Meinking A et al. Age, renal perfusion and
function in island dwelling indigenous Kuna Amerinds of Panama.
Nephron 1999; 82: 131–138.
65. Fisher ND, Hollenberg NK. Aging and vascular responses to flavanol-rich
cocoa. J Hypertens 2006; 24: 1575–1580.
66. Poggio ED, Rule AD, Tanchanco R et al. Demographic and clinical
characteristics associated with glomerular filtration rates in living kidney
donors. Kidney Int 2009; 75: 1079–1087.
67. Rule AD, Gussak HM, Pond GR et al. Measured and estimated GFR in
healthy potential kidney donors. Am J Kidney Dis 2004; 43: 112–119.
68. Barri YM, Parker TF, Daoud Y et al. Definition of chronic kidney disease
after uni-nephrectomy in living donors: what are the implications?
Transplantation 2010; 15: 575–580.
69. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum
creatinine. Nephron 1976; 16: 31–41.
70. Levey AS, Bosch J, Lewis JB. A more accurate method to estimate
glomerular filtration rate from serum creatinine: a new prediction
equation. Modification of Diet in Renal Disease Group. Ann Intern Med
1999; 130: 461–470.
71. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate
glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.
72. Wetzels JFM, Willems HL, den Heijer M. Age and gender-specific
reference values of estimated glomerular filtration rate in a Caucasian
population: results of the Nijmegen Biomedical Study. Kidney Int 2008;
73: 657–658ls.
73. Christerensson A, Elmstahl S. Estimation of the age-dependent decline of
glomerular filtration rate from formulas based on creatinine and cystatin
C in the general elderly population. Nephron Clin Pract 2011; 117:
c40–c50.
74. Hallan SI, Orth SR. The conundrum of chronic kidney disease classification
and end stage renal risk prediction in the elderly- what is the right
approach? Nephron Clin Pract 2010; 116: c307–c316.
75. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic
kidney disease. Kidney Int 2009; 75: 1009–1014.
76. National Kidney Foundation- Kidney Disease Outcomes Quality Initiative.
Clinical Practice Guidelines for chronic kidney disease- evaluation,
classification, and stratification. Am J Kidney Dis 2002; 39(Supplement 1):
s1–s246.
77. Murata K, Baumann NA, Saenger AK et al. Relative performance of the
MDRD and CKD-EPI equations for estimating glomerular filtration rate
among patients with varied clinical presentations. Clin J Am Soc Nephrol
2011; 6: 1963–1972.
78. Botev R, Mallie JP, Wetzels JF et al. The clinician and estimation of
glomerular filtration rate by creatinine-based formulas: current limitations
and quo vadis. Clin J Am Soc Nephrol 2011; 6: 937–950.
79. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention
of chronic kidney disease. Lancet 2010; 375: 1296–1309.
80. Gansevoort RT, Matsushita K, van der Velde M et al. Lower estimated GFR
and higher albuminuria are associated with adverse kidney outcomes. A
collaborative meta-analysis of general and high risk population cohorts.
Kidney Int 2011; 80: 93–104.
81. Muntner P, Bowling CB, Gao L et al. Age-specific association of reduced
estimated glomerular filtration rate and albuminuria with all cause
mortality. Clin J Am Soc Nephrol 2011; 6: 2822–2829.
82. Warnock DG, Muntner P, McCullough PA et al. Kidney function,
albuminuria and all-cause mortality in the REGARDS (Reasons for
Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 2010;
56: 861–871.
83. Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney
function, proteinuria and adverse outcomes. JAMA 2010; 303:
423–429.
84. Hallan SI, Ritz E, Lyderson S et al. Combining GFR and albuminuria to
classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20:
1069–1077.
85. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular
filtration rate and higher albuminuria are associated with mortality and
end-stage renal disease. A collaborative meta-analysis of kidney disease
population cohorts. Kidney Int 2011; 79: 1331–1340.
86. Levey AS, deJong PE, Coresh J et al. The definition, classification and
prognosis of chronic kidney disease: a KDIGO Controversies Conference
Report. Kidney Int 2011; 80: 17–28.
87. Prakash S, O’Hare AM. Interaction of aging and CKD. Semin Nephrol 2009;
29: 497–503.
88. O’Hare AM, Choi AI, Bertenthal D et al. Age affects outcome in chronic
kidney disease. J Am Soc Nephrol 2007; 18: 2758–2765.
89. O’Hare AM, Bertenthal D, Covinsky KE et al. Mortality risk stratification in
chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006; 17:
846–853.
90. James MT, Hemmelgarn BR, Wiebe N et al. Glomerular filtration rate,
proteinuria and the incidence and consequences of acute kidney injury: a
cohort study. Lancet 2010; 376: 2096–2013.
91. Stengel B, Metzger M, Froissart M et al. Epidemiology and prognostic
significance of chronic kidney disease in the elderly—the three
cities prospective cohort study. Nephrol Dial Transplant 2011; 26:
3286–3295.
92. Clase CM, Gao P, Tobe SW et al. Estimated glomerular filtration rate and
albuminuria as predictors of outcomes in patients with high cardio-
vascular risk: a cohort study. Ann Intern Med 2010; 154: 310–316.
93. Rule AD, Bailey KR, Schwartz GL et al. For estimating creatinine clearance
measuring muscle mass gives better results than those based on
demographics. Kidney Intl 2009; 75: 1071–1078.
94. Nerpin E, Ingelsson E, Riserus U et al. The combined contribution of
albuminuria and glomerular filtration rate in the prediction of
cardiovascular mortality in elderly men. Nephrol Dial Transplant
2011; 26: 2820–2827.
95. Peralta CA, Katz R, Sarnak MJ et al. Cystatin C identifies chronic kidney
disease patients at higher risk for complications. J Am Soc Nephrol 2011;
22: 147–155.
96. Stevens LA, Schmid CH, Greene T et al. Factors other than glomerular
filtration rate affect serum cystatin C levels. Kidney Int 2009; 75:
652–660.
97. Rule A, Cornell L, Poggio E. Senile nephrosclerosis - does it explain the
decline in glomerular filtration rate with aging. Nephron Physiol 2011;
119(Suppl 1): 6–11.
Kidney International (2012) 82, 270–277 277
RJ Glassock and AD Rule: The aging kidney rev iew
